Back
Halozyme Therapeutics, Inc. Stock Price Chart
Washington Wants Your Money. Here's How to Opt Out.
Learn how to become your own bank. Watch the free training.
Buy
62
HALO
Halozyme Therapeutics, Inc.
Last Price:
$70.30
Seasonality Move:
6.84%
7 Day Trial
ALL ACCESS PASS
$
7
Get Paid In ANY Crypto Market
Learn the crash-proof system. Watch the free training.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and HALO is experiencing slight selling pressure.
Halozyme Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 68.14 | Sell |
| 20-day SMA: | 65.32 | Buy |
| 50-day SMA: | 67.27 | Buy |
| 200-day SMA: | 63.63 | Buy |
| 8-day EMA: | 67.56 | Sell |
| 20-day EMA: | 66.93 | Buy |
| 50-day EMA: | 67.27 | Buy |
| 200-day EMA: | 63.99 | Buy |
Halozyme Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.24 | Buy |
| Relative Strength Index (14 RSI): | 51.52 | Buy |
| Chaikin Money Flow: | -382406 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (63.09 - 69.53) | Buy |
| Bollinger Bands (100): | (65.02 - 73.68) | Sell |
Halozyme Therapeutics, Inc. Technical Analysis
| Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Halozyme Therapeutics, Inc. Stock
Is Halozyme Therapeutics, Inc. Stock a Buy?
-
Halozyme Therapeutics, Inc. share price is 67.30 while HALO 8-day simple moving average is 68.14, which is a Sell signal.
-
The stock price of HALO is 67.30 while Halozyme Therapeutics, Inc. 20-day SMA is 65.32, which makes it a Buy.
-
Halozyme Therapeutics, Inc. 50-day simple moving average is 67.27 while HALO share price is 67.30, making it a Buy technically.
-
HALO stock price is 67.30 and Halozyme Therapeutics, Inc. 200-day simple moving average is 63.63, creating a Buy signal.
HALO Technical Analysis vs Fundamental Analysis
Buy
62
Halozyme Therapeutics, Inc. (HALO)
is a Buy
Is Halozyme Therapeutics, Inc. a Buy or a Sell?
-
Halozyme Therapeutics, Inc. stock is rated a BuyThe current Halozyme Therapeutics, Inc. [HALO] share price is $67.30. The Score for HALO is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
Halozyme Therapeutics, Inc. Stock Info
Market Cap:
8.3B
Price in USD:
67.30
Share Volume:
977.3K
Halozyme Therapeutics, Inc. 52-Week Range
52-Week High:
79.50
52-Week Low:
47.50
Buy
62
Halozyme Therapeutics, Inc. (HALO)
is a Buy
Halozyme Therapeutics, Inc. Share Price Forecast
-
What is the Halozyme Therapeutics, Inc. stock price today?The Halozyme Therapeutics, Inc. stock price is 67.30 USD today.
-
Will HALO stock go up or go down?Halozyme Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Halozyme Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Halozyme Therapeutics, Inc. is not overvalued.
Is Halozyme Therapeutics, Inc. Stock a Buy?
-
Halozyme Therapeutics, Inc. share price is 67.30 while HALO 8-day exponential moving average is 67.56, which is a Sell signal.
-
The stock price of HALO is 67.30 while Halozyme Therapeutics, Inc. 20-day EMA is 66.93, which makes it a Buy.
-
Halozyme Therapeutics, Inc. 50-day exponential moving average is 67.27 while HALO share price is 67.30, making it a Buy technically.
-
HALO stock price is 67.30 and Halozyme Therapeutics, Inc. 200-day simple moving average is 63.99, creating a Buy signal.
Fundamental Analysis of Halozyme Therapeutics, Inc.
Is Halozyme Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.31 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.88 per share, and an increase next year of $1.43 per share.
Technical Analysis of Halozyme Therapeutics, Inc.
Should I short Halozyme Therapeutics, Inc. stock?
-
HALO Moving Average Covergence Divergence (MACD) indicator is 0.24, suggesting Halozyme Therapeutics, Inc. is a Buy
-
Halozyme Therapeutics, Inc. Relative Strength Index (RSI) is 51.52, which suggest Halozyme Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Halozyme Therapeutics, Inc. is (63.09 - 69.53), which suggest Halozyme Therapeutics, Inc. is a Sell
-
The Bollinger Bands (100) for Halozyme Therapeutics, Inc. is (65.02 - 73.68), which suggest Halozyme Therapeutics, Inc. is a Sell
* Halozyme Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.